Literature DB >> 19591456

Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.

P Stephen Williams1, Francesca Carpino, Maciej Zborowski.   

Abstract

Magnetic nanoparticle drug carriers continue to attract considerable interest for drug targeting in the treatment of cancers and other pathological conditions. The efficient delivery of therapeutic levels of drug to a target site while limiting nonspecific, systemic toxicity requires optimization of the drug delivery materials, the applied magnetic field, and the treatment protocol. The history and current state of magnetic drug targeting is reviewed. While initial studies involved micrometer-sized and larger carriers, and work with these microcarriers continues, it is the sub-micrometer carriers or nanocarriers that are of increasing interest. An aspect of magnetic drug targeting using nanoparticle carriers that has not been considered is then addressed. This aspect involves the variation in the magnetic properties of the nanocarriers. Quadrupole magnetic field-flow fractionation (QMgFFF) is a relatively new technique for characterizing magnetic nanoparticles. It is unique in its capability of determining the distribution in magnetic properties of a nanoparticle sample in suspension. The development and current state of this technique is also reviewed. Magnetic nanoparticle drug carriers have been found by QMgFFF analysis to be highly polydisperse in their magnetic properties, and the strength of response of the particles to magnetic field gradients is predicted to vary by orders of magnitude. It is expected that the least magnetic fraction of a formulation will contribute the most to systemic toxicity, and the depletion of this fraction will result in a more effective drug carrying material. A material that has a reduced systemic toxicity will allow higher doses of cytotoxic drugs to be delivered to the tumor with reduced side effects. Preliminary experiments involving a novel method of refining a magnetic nanoparticle drug carrier to achieve this result are described. QMgFFF is used to characterize the refined and unrefined material.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591456      PMCID: PMC2757515          DOI: 10.1021/mp900018v

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  100 in total

Review 1.  Magnetically controlled targeted micro-carrier systems.

Authors:  P K Gupta; C T Hung
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

2.  [Organ specific application of drugs by means of cellular capsule systems (author's transl)].

Authors:  U Zimmermann; G Pilwat
Journal:  Z Naturforsch C Biosci       Date:  1976 Nov-Dec

3.  Microvascular permeability of normal and neoplastic tissues.

Authors:  L E Gerlowski; R K Jain
Journal:  Microvasc Res       Date:  1986-05       Impact factor: 3.514

4.  Magnetic microspheres: a model system of site specific drug delivery in vivo.

Authors:  K J Widder; A E Senyel; G D Scarpelli
Journal:  Proc Soc Exp Biol Med       Date:  1978-06

5.  Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.

Authors:  S C Goodwin; C A Bittner; C L Peterson; G Wong
Journal:  Toxicol Sci       Date:  2001-03       Impact factor: 4.849

6.  Analytical model of magnetic nanoparticle transport and capture in the microvasculature.

Authors:  E P Furlani; K C Ng
Journal:  Phys Rev E Stat Nonlin Soft Matter Phys       Date:  2006-06-27

7.  The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent.

Authors:  M P Desai; V Labhasetwar; E Walter; R J Levy; G L Amidon
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

8.  Theory for nanoparticle retention time in the helical channel of quadrupole magnetic field-flow fractionation.

Authors:  P Stephen Williams; Francesca Carpino; Maciej Zborowski
Journal:  J Magn Magn Mater       Date:  2009-05-01       Impact factor: 2.993

9.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.

Authors:  A S Lübbe; C Bergemann; H Riess; F Schriever; P Reichardt; K Possinger; M Matthias; B Dörken; F Herrmann; R Gürtler; P Hohenberger; N Haas; R Sohr; B Sander; A J Lemke; D Ohlendorf; W Huhnt; D Huhn
Journal:  Cancer Res       Date:  1996-10-15       Impact factor: 12.701

10.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors.

Authors:  A Gabizon; D Papahadjopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more
  7 in total

1.  Characterization of magnetic nanoparticles using programmed quadrupole magnetic field-flow fractionation.

Authors:  P Stephen Williams; Francesca Carpino; Maciej Zborowski
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2010-09-28       Impact factor: 4.226

2.  Feasibility study of red blood cell debulking by magnetic field-flow fractionation with step-programmed flow.

Authors:  Lee R Moore; P Stephen Williams; Franziska Nehl; Koji Abe; Jeffrey J Chalmers; Maciej Zborowski
Journal:  Anal Bioanal Chem       Date:  2013-10-19       Impact factor: 4.142

3.  Inverted Linear Halbach Array for Separation of Magnetic Nanoparticles.

Authors:  Y Ijiri; C Poudel; P S Williams; L R Moore; T Orita; M Zborowski
Journal:  IEEE Trans Magn       Date:  2013-07       Impact factor: 1.700

4.  Microfluidic synthesis of microfibers for magnetic-responsive controlled drug release and cell culture.

Authors:  Yung-Sheng Lin; Keng-Shiang Huang; Chih-Hui Yang; Chih-Yu Wang; Yuh-Shyong Yang; Hsiang-Chen Hsu; Yu-Ju Liao; Chia-Wen Tsai
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

Review 5.  Recent Advances in Continuous-Flow Particle Manipulations Using Magnetic Fluids.

Authors:  Xiangchun Xuan
Journal:  Micromachines (Basel)       Date:  2019-10-31       Impact factor: 2.891

Review 6.  An overview and bibliometric analysis on the colorectal cancer therapy by magnetic functionalized nanoparticles for the responsive and targeted drug delivery.

Authors:  Mahdieh Darroudi; Mehrdad Gholami; Majid Rezayi; Majid Khazaei
Journal:  J Nanobiotechnology       Date:  2021-11-29       Impact factor: 10.435

7.  Cytotoxic Activities of Silver Nanoparticles and Silver Ions in Parent and Tamoxifen-Resistant T47D Human Breast Cancer Cells and Their Combination Effects with Tamoxifen against Resistant Cells.

Authors:  Seyed Naser Ostad; Shahrzad Dehnad; Zeinab Esmail Nazari; Shohreh Tavajohi Fini; Narges Mokhtari; Mojtaba Shakibaie; Ahmad Reza Shahverdi
Journal:  Avicenna J Med Biotechnol       Date:  2010-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.